Novartis CSEG101AIC05


2.10.1.27 per eCOA
Sep 2, 2021

A proposito di Novartis CSEG101AIC05

L'app Novartis CSEG101AIC05 utilizza il diario del dolore delle cellule falciformi - Self Report (SCPD-S)

Novartis CSEG101AIC05 app is using Sickle Cell Pain Diary – Self Report (SCPD-S) to help patients self record their experiences with sickle cell pain and pain crises during the preceding 24 hours in a digital diary. These patient reported outcomes would be collected in a non-interventional clinical study, CSEG101AIC05 (SPOTLIGHT). The SCPD-S was developed in conjunction with patients, their caregivers and health care providers in accordance with the US Food and Drug Administration (FDA) patient reported outcome (PRO) guidance. It consists of 19 items or 4 items (determined by the answer to the first question), developed for use in people aged ≥ 12 years.

Novità nell'ultima versione 2.10.1.27

Last updated on Apr 7, 2022
New languages

Informazioni APP aggiuntive

Ultima versione

2.10.1.27

Caricata da

Chabroullet Stephane

È necessario Android

Android 4.4+

Available on

Mostra Altro

Use APKPure App

Get Novartis CSEG101AIC05 old version APK for Android

Scarica

Use APKPure App

Get Novartis CSEG101AIC05 old version APK for Android

Scarica

Novartis CSEG101AIC05 Alternativa

Trova altro da eCOA

Scoprire